Form D · Other Health Care
Contango Labs
New York City, NY · CIK 0001743012
Offering snapshot reported Jun 14, 2018 · SEC filing
- Reported sold
- $65K Offering amount: $265K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $40K Reported outside-investor minimum
- First sale
- Jun 4, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2018 | Initial | $65,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 04.3
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-314594
Source: Form D, filed Jun 14, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris Swartout | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
340 East 52nd Street Unit 4 C
New York City, NY, 10022
New York City, NY, 10022